MIR548AW

Across TCGA pan-cancer cohorts, MIR548AW RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR548AW data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR548AW RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AW expression acts as an unfavorable survival marker.

HNSC, ACC, and THCA are the cancer types where MIR548AW RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.160	0.728	<.001	108	view →
ACC	DFS	Tertile	II,III,IV	0.010	0.632	<.001	99	view →
THCA	DFS	Tertile	All	0.359	0.837	<.001	72	view →
LUSC	OS	Tertile	II,III,IV	0.112	0.733	<.001	54	view →
KIRC	DFS	Tertile	IV	0.038	0.643	<.001	36	view →
READ	DFS	Tertile	All	0.179	0.701	.022	27	view →
SARC	OS	Tertile	All	0.274	0.737	.002	18	view →
PRAD	OS	Tertile	All	0.894	0.992	<.001	18	view →
SKCM	OS	Tertile	II,III,IV	0.486	0.845	.030	9	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR548AW–HNSC (OS)

Open the HNSC breakdown →